"AOP Orphan is an agile company operating worldwide via own local enterprises and partnerships. Each country has its own regulations that apply to drug research and development, manufacturing, marketing and post marketing activities - to name a few. At AOP Orphan we do our best to keep up the high standards at every step for the health and safety of the patients!"
Personal Data Sheet
Anna Damgaard Jensen received her Master Degree of Laws from the University of Copenhagen, Denmark and has been continuing her education afterwards at Medicademy in Copenhagen, Denmark, Falconbury and Management Forum in London, UK among others.
She gathered profound life science and intellectual property experience at the major Danish law firm Kromann Reumert in Copenhagen and Boehringer Ingelheim RCV GmbH & Co KG in Vienna, joining AOP Orphan in June 2019 as a Head of Legal and was promoted to Director Legal Affairs in January 2020.
Anna is fluent in English, German, Danish and has a basic knowledge of Norwegian and Swedish.